The Relationship Between Pediatric Combination Vaccines and Market Effects.

We explored market factors that affect pediatric combination vaccine uptake in the US public-sector pediatric vaccine market. We specifically examined how Pediarix and Pentacel earned a place in the 2009-2012 lowest overall cost formulary. Direct competition between Pediarix and Pentacel is driven b...

Descripción completa

Detalles Bibliográficos
Publicado en:	American Journal of Public Health Vol. 104; no. 6; pp. 998 - 1005
Autores principales:	Behzad, Banafsheh, Jacobson, Sheldon H., Jokela, Janet A., Sewell, Edward C.
Formato:	Journal Article
Publicado:	American Public Health Association Jun2014
Materias:	United States Computer simulation Cost effectiveness Immunization Retrospective studies Economic competition Vaccination Antigens Contracting out DPT vaccines Haemophilus influenzae Hepatitis B vaccines Medical protocols Medical prescriptions Pharmaceutical industry Pneumococcal vaccines Policy science research Vaccines Combined vaccines
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Sumario:	We explored market factors that affect pediatric combination vaccine uptake in the US public-sector pediatric vaccine market. We specifically examined how Pediarix and Pentacel earned a place in the 2009-2012 lowest overall cost formulary. Direct competition between Pediarix and Pentacel is driven by the indirect presence of the Merck Haemophilus influenzae type b vaccine and the Recommended Childhood Immunization Schedule requirement for a hepatitis B birth dose. The resulting analysis suggests that Pentacel would never have earned a place in the lowest overall cost formulary for 2009-2012 federal contract prices for any cost of an injection unless the Merck H influenzae type b advantage was ignored and the hepatitis B birth dose administration cost was recognized by health care providers in designing the lowest overall cost formularies.